Related Experiment Videos

[Hyperhomocysteinemia and cardiovascular risk in diabetes mellitus]

Giuseppina T Russo1, Domenico Cucinotta

  • 1Dipartimento di Medicina Interna, Università degli Studi, Messina. russogiusi@tin.it

Annali Dell'Istituto Superiore Di Sanita
|November 1, 2003
PubMed

Insights

Mild hyperhomocysteinemia is an independent risk factor for cardiovascular disease in diabetic patients, not directly linked to diabetes itself. Fasting homocysteine levels are influenced by kidney function (glomerular filtration rate).

Area of Science:

  • Endocrinology
  • Nephrology
  • Cardiology

Context:

  • Cardiovascular disease (CVD) is a leading cause of mortality in individuals with diabetes.
  • Hyperglycemia alone does not fully account for the elevated CVD risk in diabetics.
  • Mild hyperhomocysteinemia is recognized as an independent risk factor for atherosclerosis in the general population.

Purpose:

  • To investigate the association between hyperhomocysteinemia and cardiovascular disease risk in diabetic patients.
  • To clarify the relationship between homocysteine levels, diabetes, and kidney function.

Summary:

  • Fasting homocysteine plasma levels in diabetic subjects are primarily determined by glomerular filtration rate (GFR), not diabetes itself.
  • While controversial for diabetic retinopathy and neuropathy, hyperhomocysteinemia is consistently identified as an independent risk factor for cardiovascular disease in diabetes.

Impact:

  • Highlights hyperhomocysteinemia as a critical, independent cardiovascular risk factor in diabetic populations.
  • Suggests that managing kidney function may influence homocysteine levels in diabetics.
  • Informs clinical practice regarding cardiovascular risk assessment and management in diabetic patients.

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Complications of Diabetes Mellitus01:22

Complications of Diabetes Mellitus

Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.